This center treats primary substance use disorders and co-occurring mental health conditions. Your treatment plan addresses each condition at once with personalized, compassionate care for comprehensive healing.
Outpatient treatment offers flexible therapeutic and medical care without the need to stay overnight in a hospital or inpatient facility. Some centers off intensive outpatient program (IOP), which falls between inpatient care and traditional outpatient service.
Recovery.com has connected directly with this treatment provider to validate the information in their profile.
This center treats primary substance use disorders and co-occurring mental health conditions. Your treatment plan addresses each condition at once with personalized, compassionate care for comprehensive healing.
Outpatient treatment offers flexible therapeutic and medical care without the need to stay overnight in a hospital or inpatient facility. Some centers off intensive outpatient program (IOP), which falls between inpatient care and traditional outpatient service.
We accept Medicare, Medicaid and commercial insurance. We are in-network with most health plans and work with patients to procure coverage when needed.
CleanSlate Centers in Waukesha is an outpatient program that offers behavioral healthcare and integrative, specialized treatment for addiction. They provide comprehensive and personally tailored recovery plans for adults, specializing in medication-assisted treatment (MAT) for individuals struggling with alcohol, heroin, or other opioid addictions. Clients can receive MAT to help reduce cravings and any physical symptoms of withdrawal, while receiving additional support for co-occurring mental health disorders such as depression, trauma, or anxiety through CleanSlate’s outpatient program.
CleanSlate offers an integrative approach to treatment, providing personally tailored treatment plans to meet each individuals unique needs and addressing any underlying mental, emotional, spiritual, physical, and social factors. Their comprehensive methods offer clients support through MAT, 1-on-1 therapy, outpatient programs, and aftercare support through certified recovery coaches along with continuing care coordination.
Licensed and compassionate clinicians work with patients in need of medication-assisted treatment (MAT) for a physical dependency to alcohol or opioids. MAT is an evidence-based treatment approach, alleviating the physical symptoms of withdrawal and reducing the pleasurable effects of opioid or alcohol use. Medications such as Suboxone or Vivitrol are FDA-approved, and in conjunction with counseling and mental and behavioral health support, have been shown to lead to long-term sobriety. CleanSlate also offers a specialized program for pregnant women, providing MAT and medical monitoring that focuses on the safety of the mother and unborn child. They can also provide treatment for poly-substance use, treating clients who are addicted to a combination of drugs, along with treatment for co-occurring mental health disorders
Along with MAT, CleanSlate offers patients mental and behavioral health support through their outpatient program. Clients may participate in group therapy sessions that provide peer support, individual therapy, family therapy sessions, and have access to certified recovery coaches and aftercare support, providing care coordination and community resources. CleanSlate care coordinators help connect clients to post-treatment support, ensuring access to housing, food, transportation, education, and employment. In addition to their specialized programming for pregnant women, they also treat individuals with nicotine addiction, and individuals with Hepatitis C.
CleanSlate provides clients and their families with long-term support through a combination of medical care, evidence-based treatments, behavioral health therapy, personalized recovery plans, and community support. They accept medicaid, medicare, and most commercial insurances, and are a CARF accredited facility.
This center treats primary substance use disorders and co-occurring mental health conditions. Your treatment plan addresses each condition at once with personalized, compassionate care for comprehensive healing.
CARF stands for the Commission on Accreditation of Rehabilitation Facilities. It's an independent, non-profit organization that provides accreditation services for a variety of healthcare services. To be accredited means that the program meets their standards for quality, effectiveness, and person-centered care.
Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT
Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.
Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.
Suboxone®, Subutex®, Sublocade®, Zubsolv®
Buprenorphine is a partial opioid agonist used to treat opioid use disorder. It activates opioid receptors to reduce cravings and withdrawal but has a ceiling effect, meaning it produces less euphoria and respiratory depression than full opioids.
Buprenorphine binds tightly to opioid receptors, blocking other opioids from attaching and reducing the risk of misuse. It's often combined with naloxone (as in Suboxone®) to discourage injection misuse and is available in daily or monthly forms.